SCHEMBL31455322

SCHEMBL31455322

CCCCOC(=O)N1CC(c2ccc(N)cc2)C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.51
CYP1A2 P05177 2/20 0.51
CYP3A4 P08684 2/20 0.51
TSHR P16473 2/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
PDE4D Q08499 1/20 0.51
ALDH1A1 P00352 5/20 0.46
RAB9A P51151 2/20 0.46
NPC1 O15118 1/20 0.46
MAPT P10636 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.43
POLB P06746 1/20 0.43
CHRM2 P08172 1/20 0.42
HTR1A P08908 1/20 0.42
GAA P10253 1/20 0.42
CYP2D6 P10635 1/20 0.42
DRD3 P35462 1/20 0.42
SCN1A P35498 1/20 0.42
SLC6A3 Q01959 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2025839 0.90 PDE4B (0.53) LMNACYP1A2CYP3A4TSHRCYP2C9
SCHEMBL23040449 0.89 LMNA (0.49) LMNACYP1A2CYP3A4TSHRCYP2C9
SCHEMBL30376364 0.87 LMNA (0.49) LMNACYP1A2CYP3A4TSHRCYP2C9
SCHEMBL2047643 0.80 LMNA (0.45) LMNACYP1A2CYP3A4TSHRCYP2C9
SCHEMBL29649885 0.80 LMNA (0.47) LMNACYP1A2CYP3A4TSHRCYP2C9
SCHEMBL30711495 0.79 KDM4E (0.47) LMNACYP3A4TSHRALDH1A1RAB9A
SCHEMBL2023788 0.79 LMNA (0.49) LMNACYP1A2CYP3A4TSHRCYP2C9
SCHEMBL30013275 0.78 MGLL (0.38) LMNARAB9ASMN1; SMN2POLBDRD3
SCHEMBL31421713 0.77 LMNA (0.47) LMNACYP1A2CYP3A4TSHRCYP2C9
SCHEMBL15531501 0.77 LMNA (0.50) LMNACYP1A2CYP3A4TSHRCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059577-A1 SUBSTITUTED AMINOPYRIDINE COMPOUNDS FOR USE AS AKT1 INHIBITORS ATAVISTIK BIO, INC. (US) 2025-03-20 WO disclosed